HAVCR1 and kidney injury: In contrast, the administration of Cana in a dose-dependent manner (10 mg/kg and 25 mg/kg) significantly diminished the increment of kidney function tests and tubular injury markers NGAL, as well as, KIM-1, compared to the APAP group, verifying Cana’s beneficial effect in rescuing cells from APAP-induced kidney injury.